Peptides are back in the news — but Dr. Bob says the headlines are misleading. In this follow-up to their original peptides episode, Dr. Bob and Dave break down what an FDA advisory panel's recent vote on the 503A bulk list actually means (and doesn't mean), why several panel members have financial ties to the peptide industry, and how listeners can independently check the real evidence behind any compound before spending their money.

0:13 Welcome Back & What's Been in the News on Peptides

0:39 Clarifying the FDA's 503A Bulk List Vote

1:37 Conflict of Interest: Who's Actually on the Advisory Panel?

2:26 What Is a Compound Pharmacy, Really?

4:35 Supplement Industry vs. Pharmaceutical Industry

10:16 How to Vet Peptides Yourself

Key Takeaways

• The FDA has not approved or endorsed peptides. An advisory panel voted only on whether certain peptide compounds should be restored to the 503A bulk list — the list that governs what compound pharmacies are legally allowed to use.
• Several advisory panel members reportedly have financial ties to the peptide industry, raising real conflict-of-interest concerns about the vote's legitimacy.
• A regulatory vote like this can create an "illusion of credibility" that the public mistakes for proof of safety or effectiveness — it's neither.
• Before trying any peptide, ask for two specific things: published safety data and published efficacy data — not testimonials or anecdotes.
• Use AI search tools to quickly check for real published clinical data on a specific compound rather than relying on marketing claims.
• Follow the Market Signals: If a peptide had proven, robust efficacy and clear safety, major pharmaceutical companies would be actively manufacturing and commercializing it, much like GLP-1 agonists.
• 
  
• Visit Dr. Driver at Spartan Medical Associates: https://spartanmedicalassociates.com/
• Have a question for the show? Email us at: contact@healthnotes.net

FDA Announcement: https://www.fda.gov/drugs/drug-alerts-and-statements/fda-publishes-revised-draft-product-specific-guidances-certain-generic-peptide-products

Disclaimer:

This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information and the materials linked to this podcast is at the user's own risk. The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions.

This podcast is purely for educational and entertainment purposes. Listening to our show does not create a doctor patient relationship. While I am a doctor, and we speak with other medical providers, we are not your doctor. The content you hear should never replace professional medical advice, diagnosis, or treatment, so always consult your personal physician regarding your own health.